{"database": "open_comments", "table": "documents", "is_view": false, "human_description_en": "where agency_id = \"FDA\" and document_type = \"Other\" sorted by comment_end_date descending", "rows": [["FDA-2026-P-0749-0001", "FDA", "FDA-2026-P-0749", "Citizen Petition from Apotex Inc.", "Other", "Citizen Petition", "2026-01-26", 2026, 1, "2026-01-26", "2026-07-23", "2026-01-27 01:08:18", null, 1, 0, "09000064b9182c73"], ["FDA-2026-D-1255-0002", "FDA", "FDA-2026-D-1255", "Safety Assessment of Genome Editing in Human Gene Therapy Products Using Next-Generation Sequencing; Draft Guidance for Industry", "Other", "Guidance", "2026-04-15", 2026, 4, "2026-04-15", "2026-07-15", "2026-04-16 09:00:16", null, 1, 0, "09000064b9282a2a"], ["FDA-2025-D-2837-0002", "FDA", "FDA-2025-D-2837", "Questions and Answers About Requirements for Additional Traceability Records for Certain Foods: Guidance for Industry - Draft Guidance", "Other", "Guidance", "2026-02-20", 2026, 2, "2026-02-20", "2026-05-22", "2026-02-20 20:47:16", null, 1, 0, "09000064b91c9d9a"], ["FDA-2026-N-1304-0001", "FDA", "FDA-2026-N-1304", "Agenda for the U.S. Food and Drug Administration (FDA) Virtual Public Meeting Food Allergen Thresholds and Their Potential Applications 2-18-2026", "Other", "Agenda", "2026-02-18", 2026, 2, "2026-02-18", "2026-05-20", "2026-04-10 09:00:23", null, 1, 0, "09000064b91b5eeb"], ["FDA-2025-D-6131-0002", "FDA", "FDA-2025-D-6131", "General Considerations for the Use of New Approach Methodologies in Drug Development; Guidance for Industry - Draft Guidance", "Other", "Guidance", "2026-03-19", 2026, 3, "2026-03-19", "2026-05-19", "2026-04-15 09:00:24", null, 1, 0, "09000064b9223609"], ["FDA-2026-D-1817-0002", "FDA", "FDA-2026-D-1817", "Flavored Electronic Nicotine Delivery Systems (ENDS) Premarket Applications\u2014Considerations Related to Youth Risk - Draft Guidance for Industry", "Other", "Guidance", "2026-03-11", 2026, 3, "2026-03-11", "2026-05-12", "2026-04-14 09:00:19", null, 1, 0, "09000064b920c96d"], ["FDA-2011-D-0611-0094", "FDA", "FDA-2011-D-0611", "New and Revised Draft Q&As on Biosimilar Development and the BPCI Act (Revision 4) Guidance for Industry - \nDraft Guidance", "Other", "Guidance", "2026-03-10", 2026, 3, "2026-03-10", "2026-05-12", "2026-03-14 09:00:14", null, 1, 0, "09000064b92071bb"], ["FDA-2025-D-1504-0002", "FDA", "FDA-2025-D-1504", "Responding to FDA Form 483 Observations at the Conclusion of a Drug CGMP Inspection: Draft Guidance for Industry", "Other", "Guidance", "2026-03-09", 2026, 3, "2026-03-09", "2026-05-09", "2026-04-10 09:00:26", null, 1, 0, "09000064b9200f6d"], ["FDA-2024-D-4388-0002", "FDA", "FDA-2024-D-4388", "New Clinical Investigation Exclusivity (3-Year Exclusivity) for Drug Products: Questions and Answers Guidance for Industry - Draft Guidance", "Other", "Guidance", "2026-03-04", 2026, 3, "2026-03-04", "2026-05-05", "2026-03-09 09:00:19", null, 1, 0, "09000064b91ef6ec"], ["FDA-2007-D-0369-2444", "FDA", "FDA-2007-D-0369", "PSG_020151 - Draft Guidance on Venlafaxine Hydrochloride", "Other", "Guidance", "2026-02-27", 2026, 2, "2026-02-27", "2026-04-29", "2026-02-27 19:22:37", null, 1, 0, "09000064b91df4e6"], ["FDA-2007-D-0369-2442", "FDA", "FDA-2007-D-0369", "PSG_020144 - Draft Guidance on Nitroglycerin", "Other", "Guidance", "2026-02-27", 2026, 2, "2026-02-27", "2026-04-29", "2026-02-27 19:21:57", null, 1, 0, "09000064b91df4d8"], ["FDA-2007-D-0369-2432", "FDA", "FDA-2007-D-0369", "PSG_018084 - Draft Guidance on Tolmetin Sodium", "Other", "Guidance", "2026-02-27", 2026, 2, "2026-02-27", "2026-04-29", "2026-02-27 19:18:51", null, 1, 0, "09000064b91df465"], ["FDA-2007-D-0369-2457", "FDA", "FDA-2007-D-0369", "PSG_021336 - Draft Guidance on Selegiline", "Other", "Guidance", "2026-02-27", 2026, 2, "2026-02-27", "2026-04-29", "2026-02-27 19:26:39", null, 1, 0, "09000064b91e011b"], ["FDA-2007-D-0369-2440", "FDA", "FDA-2007-D-0369", "PSG_019982 - Draft Guidance on Bisoprolol Fumarate", "Other", "Guidance", "2026-02-27", 2026, 2, "2026-02-27", "2026-04-29", "2026-02-27 19:21:21", null, 1, 0, "09000064b91df4d4"], ["FDA-2007-D-0369-2447", "FDA", "FDA-2007-D-0369", "PSG_020375 - Draft Guidance on Estradiol", "Other", "Guidance", "2026-02-27", 2026, 2, "2026-02-27", "2026-04-29", "2026-02-27 19:23:38", null, 1, 0, "09000064b91df4f2"], ["FDA-2007-D-0369-2438", "FDA", "FDA-2007-D-0369", "PSG_019813 - Draft Guidance on Fentanyl", "Other", "Guidance", "2026-02-27", 2026, 2, "2026-02-27", "2026-04-29", "2026-02-27 19:20:47", null, 1, 0, "09000064b91df4d0"], ["FDA-2007-D-0369-2459", "FDA", "FDA-2007-D-0369", "PSG_021427 - Draft Guidance on Duloxetine Hydrochloride", "Other", "Guidance", "2026-02-27", 2026, 2, "2026-02-27", "2026-04-29", "2026-02-27 19:27:37", null, 1, 0, "09000064b91e011f"], ["FDA-2007-D-0369-2461", "FDA", "FDA-2007-D-0369", "PSG_021514 - Draft Guidance on Methylphenidate", "Other", "Guidance", "2026-02-27", 2026, 2, "2026-02-27", "2026-04-29", "2026-02-27 19:29:28", null, 1, 0, "09000064b91e0123"], ["FDA-2007-D-0369-2520", "FDA", "FDA-2007-D-0369", "PSG_218466 - Draft Guidance on Alpelisib", "Other", "Guidance", "2026-02-27", 2026, 2, "2026-02-27", "2026-04-29", "2026-02-27 19:50:12", null, 1, 0, "09000064b91e01d3"], ["FDA-2007-D-0369-2511", "FDA", "FDA-2007-D-0369", "PSG_216352 - Draft Guidance on Paliperidone Palmitate", "Other", "Guidance", "2026-02-27", 2026, 2, "2026-02-27", "2026-04-29", "2026-02-27 19:47:03", null, 1, 0, "09000064b91e01b4"], ["FDA-2007-D-0369-2512", "FDA", "FDA-2007-D-0369", "PSG_216665 - Draft Guidance on Diazoxide Choline", "Other", "Guidance", "2026-02-27", 2026, 2, "2026-02-27", "2026-04-29", "2026-02-27 19:47:20", null, 1, 0, "09000064b91e01b6"], ["FDA-2007-D-0369-2508", "FDA", "FDA-2007-D-0369", "PSG_215431 - Draft Guidance on Meloxicam; Rizatriptan Benzoate", "Other", "Guidance", "2026-02-27", 2026, 2, "2026-02-27", "2026-04-29", "2026-02-27 19:46:07", null, 1, 0, "09000064b91e01ad"], ["FDA-2007-D-0369-2475", "FDA", "FDA-2007-D-0369", "PSG_202211 - Draft Guidance on Oxybutynin", "Other", "Guidance", "2026-02-27", 2026, 2, "2026-02-27", "2026-04-29", "2026-02-27 19:35:11", null, 1, 0, "09000064b91e0140"], ["FDA-2007-D-0369-2466", "FDA", "FDA-2007-D-0369", "PSG_022029 - Draft Guidance on Menthol; Methyl Salicylate", "Other", "Guidance", "2026-02-27", 2026, 2, "2026-02-27", "2026-04-29", "2026-02-27 19:31:54", null, 1, 0, "09000064b91e012d"], ["FDA-2007-D-0369-2467", "FDA", "FDA-2007-D-0369", "PSG_022083 - Draft Guidance on Rivastigmine", "Other", "Guidance", "2026-02-27", 2026, 2, "2026-02-27", "2026-04-29", "2026-02-27 19:32:28", null, 1, 0, "09000064b91e012f"], ["FDA-2007-D-0369-2464", "FDA", "FDA-2007-D-0369", "PSG_021829 - Draft Guidance on Rotigotine", "Other", "Guidance", "2026-02-27", 2026, 2, "2026-02-27", "2026-04-29", "2026-02-27 19:30:54", null, 1, 0, "09000064b91e0129"], ["FDA-2007-D-0369-2497", "FDA", "FDA-2007-D-0369", "PSG_213224 - Draft Guidance on Octreotide acetate", "Other", "Guidance", "2026-02-27", 2026, 2, "2026-02-27", "2026-04-29", "2026-02-27 19:42:17", null, 1, 0, "09000064b91e018a"], ["FDA-2007-D-0369-2490", "FDA", "FDA-2007-D-0369", "PSG_211843 - Draft Guidance on Tiopronin", "Other", "Guidance", "2026-02-27", 2026, 2, "2026-02-27", "2026-04-29", "2026-02-27 19:39:55", null, 1, 0, "09000064b91e0172"], ["FDA-2007-D-0369-2481", "FDA", "FDA-2007-D-0369", "PSG_207620 - Draft Guidance on Sacubitril; Valsartan", "Other", "Guidance", "2026-02-27", 2026, 2, "2026-02-27", "2026-04-29", "2026-02-27 19:37:17", null, 1, 0, "09000064b91e0156"], ["FDA-2007-D-0369-2489", "FDA", "FDA-2007-D-0369", "PSG_211733 - Draft Guidance on Acetaminophen; Ibuprofen", "Other", "Guidance", "2026-02-27", 2026, 2, "2026-02-27", "2026-04-29", "2026-02-27 19:39:39", null, 1, 0, "09000064b91e0170"], ["FDA-2007-D-0369-2479", "FDA", "FDA-2007-D-0369", "PSG_206089 - Draft Guidance on Testosterone Undecanoate", "Other", "Guidance", "2026-02-27", 2026, 2, "2026-02-27", "2026-04-29", "2026-02-27 19:36:31", null, 1, 0, "09000064b91e0152"], ["FDA-2007-D-0369-2469", "FDA", "FDA-2007-D-0369", "PSG_022264 - Draft Guidance on Paliperidone Palmitate", "Other", "Guidance", "2026-02-27", 2026, 2, "2026-02-27", "2026-04-29", "2026-02-27 19:33:09", null, 1, 0, "09000064b91e0133"], ["FDA-2007-D-0369-2473", "FDA", "FDA-2007-D-0369", "PSG_085635 - Draft Guidance on Testosterone Cypionate", "Other", "Guidance", "2026-02-27", 2026, 2, "2026-02-27", "2026-04-29", "2026-02-27 19:34:27", null, 1, 0, "09000064b91e013c"], ["FDA-2007-D-0369-2488", "FDA", "FDA-2007-D-0369", "PSG_210868 - Draft Guidance on Lorlatinib", "Other", "Guidance", "2026-02-27", 2026, 2, "2026-02-27", "2026-04-29", "2026-02-27 19:39:21", null, 1, 0, "09000064b91e016e"], ["FDA-2007-D-0369-2486", "FDA", "FDA-2007-D-0369", "PSG_209310 - Draft Guidance on Mometasone Furoate", "Other", "Guidance", "2026-02-27", 2026, 2, "2026-02-27", "2026-04-29", "2026-02-27 19:38:46", null, 1, 0, "09000064b91e016a"], ["FDA-2007-D-0369-2506", "FDA", "FDA-2007-D-0369", "PSG_215401 - Draft Guidance on Dextroamphetamine", "Other", "Guidance", "2026-02-27", 2026, 2, "2026-02-27", "2026-04-29", "2026-02-27 19:45:23", null, 1, 0, "09000064b91e01a9"], ["FDA-2007-D-0369-2522", "FDA", "FDA-2007-D-0369", "PSG_218585 - Draft Guidance on Aceclidine Hydrochloride", "Other", "Guidance", "2026-02-27", 2026, 2, "2026-02-27", "2026-04-29", "2026-02-27 19:51:02", null, 1, 0, "09000064b91e01d7"], ["FDA-2007-D-0369-2509", "FDA", "FDA-2007-D-0369", "PSG_215602 - Draft Guidance on Baclofen", "Other", "Guidance", "2026-02-27", 2026, 2, "2026-02-27", "2026-04-29", "2026-02-27 19:46:21", null, 1, 0, "09000064b91e01af"], ["FDA-2007-D-0369-2516", "FDA", "FDA-2007-D-0369", "PSG_217225 - Draft Guidance on Avacincaptad Pegol Sodium", "Other", "Guidance", "2026-02-27", 2026, 2, "2026-02-27", "2026-04-29", "2026-02-27 19:48:56", null, 1, 0, "09000064b91e01cb"], ["FDA-2007-D-0369-2507", "FDA", "FDA-2007-D-0369", "PSG_215429 - Draft Guidance on Venlafaxine Besylate", "Other", "Guidance", "2026-02-27", 2026, 2, "2026-02-27", "2026-04-29", "2026-02-27 19:45:49", null, 1, 0, "09000064b91e01ab"], ["FDA-2007-D-0369-2443", "FDA", "FDA-2007-D-0369", "PSG_020145 - Draft Guidance on Nitroglycerin", "Other", "Guidance", "2026-02-27", 2026, 2, "2026-02-27", "2026-04-29", "2026-02-27 19:22:16", null, 1, 0, "09000064b91df4da"], ["FDA-2007-D-0369-2460", "FDA", "FDA-2007-D-0369", "PSG_021447 - Draft Guidance on Tizanidine Hydrochloride", "Other", "Guidance", "2026-02-27", 2026, 2, "2026-02-27", "2026-04-29", "2026-02-27 19:27:59", null, 1, 0, "09000064b91e0121"], ["FDA-2007-D-0369-2446", "FDA", "FDA-2007-D-0369", "PSG_020357 - Draft Guidance on Metformin Hydrochloride", "Other", "Guidance", "2026-02-27", 2026, 2, "2026-02-27", "2026-04-29", "2026-02-27 19:23:14", null, 1, 0, "09000064b91df4f0"], ["FDA-2007-D-0369-2448", "FDA", "FDA-2007-D-0369", "PSG_020489 - Draft Guidance on Testosterone", "Other", "Guidance", "2026-02-27", 2026, 2, "2026-02-27", "2026-04-29", "2026-02-27 19:23:57", null, 1, 0, "09000064b91df4f4"], ["FDA-2007-D-0369-2454", "FDA", "FDA-2007-D-0369", "PSG_021234 - Draft Guidance on Diclofenac Epolamine", "Other", "Guidance", "2026-02-27", 2026, 2, "2026-02-27", "2026-04-29", "2026-02-27 19:25:35", null, 1, 0, "09000064b91e010a"], ["FDA-2007-D-0369-2500", "FDA", "FDA-2007-D-0369", "PSG_214410 - Draft Guidance on Baloxavir Marboxil", "Other", "Guidance", "2026-02-27", 2026, 2, "2026-02-27", "2026-04-29", "2026-02-27 19:43:31", null, 1, 0, "09000064b91e0190"], ["FDA-2007-D-0369-2494", "FDA", "FDA-2007-D-0369", "PSG_212516 - Draft Guidance on Duloxetine Hydrochloride", "Other", "Guidance", "2026-02-27", 2026, 2, "2026-02-27", "2026-04-29", "2026-02-27 19:41:20", null, 1, 0, "09000064b91e0184"], ["FDA-2007-D-0369-2484", "FDA", "FDA-2007-D-0369", "PSG_208143 - Draft Guidance on Barium Sulfate", "Other", "Guidance", "2026-02-27", 2026, 2, "2026-02-27", "2026-04-29", "2026-02-27 19:38:13", null, 1, 0, "09000064b91e015c"], ["FDA-2007-D-0369-2495", "FDA", "FDA-2007-D-0369", "PSG_212526 - Draft Guidance on Alpelisib", "Other", "Guidance", "2026-02-27", 2026, 2, "2026-02-27", "2026-04-29", "2026-02-27 19:41:39", null, 1, 0, "09000064b91e0186"], ["FDA-2007-D-0369-2476", "FDA", "FDA-2007-D-0369", "PSG_203479 - Draft Guidance on Clozapine", "Other", "Guidance", "2026-02-27", 2026, 2, "2026-02-27", "2026-04-29", "2026-02-27 19:35:30", null, 1, 0, "09000064b91e014c"], ["FDA-2007-D-0369-2482", "FDA", "FDA-2007-D-0369", "PSG_207962 - Draft Guidance on Lidocaine", "Other", "Guidance", "2026-02-27", 2026, 2, "2026-02-27", "2026-04-29", "2026-02-27 19:37:34", null, 1, 0, "09000064b91e0158"], ["FDA-2007-D-0369-2480", "FDA", "FDA-2007-D-0369", "PSG_206968 - Draft Guidance on Acetaminophen", "Other", "Guidance", "2026-02-27", 2026, 2, "2026-02-27", "2026-04-29", "2026-02-27 19:36:59", null, 1, 0, "09000064b91e0154"], ["FDA-2007-D-0369-2429", "FDA", "FDA-2007-D-0369", "PSG_012283 - Draft Guidance on Chlorthalidone", "Other", "Guidance", "2026-02-27", 2026, 2, "2026-02-27", "2026-04-29", "2026-02-27 19:17:46", null, 1, 0, "09000064b91df45f"], ["FDA-2007-D-0369-2441", "FDA", "FDA-2007-D-0369", "PSG_020076 - Draft Guidance on Nicotine", "Other", "Guidance", "2026-02-27", 2026, 2, "2026-02-27", "2026-04-29", "2026-02-27 19:21:38", null, 1, 0, "09000064b91df4d6"], ["FDA-2007-D-0369-2435", "FDA", "FDA-2007-D-0369", "PSG_018891 - Draft Guidance on Clonidine", "Other", "Guidance", "2026-02-27", 2026, 2, "2026-02-27", "2026-04-29", "2026-02-27 19:19:51", null, 1, 0, "09000064b91df4ca"], ["FDA-2007-D-0369-2453", "FDA", "FDA-2007-D-0369", "PSG_021180 - Draft Guidance on Ethinyl Estradiol; Norelgestromin", "Other", "Guidance", "2026-02-27", 2026, 2, "2026-02-27", "2026-04-29", "2026-02-27 19:25:18", null, 1, 0, "09000064b91e0108"], ["FDA-2007-D-0369-2439", "FDA", "FDA-2007-D-0369", "PSG_019927 - Draft Guidance on Ketoconazole", "Other", "Guidance", "2026-02-27", 2026, 2, "2026-02-27", "2026-04-29", "2026-02-27 19:21:03", null, 1, 0, "09000064b91df4d2"], ["FDA-2007-D-0369-2523", "FDA", "FDA-2007-D-0369", "PSG_219016 - Draft Guidance on Rilpivirine Hydrochloride", "Other", "Guidance", "2026-02-27", 2026, 2, "2026-02-27", "2026-04-29", "2026-02-27 19:51:25", null, 1, 0, "09000064b91e01d9"], ["FDA-2007-D-0369-2514", "FDA", "FDA-2007-D-0369", "PSG_216962 - Draft Guidance on Foscarbidopa; Foslevodopa", "Other", "Guidance", "2026-02-27", 2026, 2, "2026-02-27", "2026-04-29", "2026-02-27 19:48:20", null, 1, 0, "09000064b91e01ba"], ["FDA-2007-D-0369-2517", "FDA", "FDA-2007-D-0369", "PSG_217370 - Draft Guidance on Acoltremon", "Other", "Guidance", "2026-02-27", 2026, 2, "2026-02-27", "2026-04-29", "2026-02-27 19:49:14", null, 1, 0, "09000064b91e01cd"], ["FDA-2007-D-0369-2515", "FDA", "FDA-2007-D-0369", "PSG_217202 - Draft Guidance on Landiolol Hydrochloride", "Other", "Guidance", "2026-02-27", 2026, 2, "2026-02-27", "2026-04-29", "2026-02-27 19:48:39", null, 1, 0, "09000064b91e01bc"], ["FDA-2007-D-0369-2492", "FDA", "FDA-2007-D-0369", "PSG_212304 - Draft Guidance on Donepezil Hydrochloride", "Other", "Guidance", "2026-02-27", 2026, 2, "2026-02-27", "2026-04-29", "2026-02-27 19:40:33", null, 1, 0, "09000064b91e0180"], ["FDA-2007-D-0369-2503", "FDA", "FDA-2007-D-0369", "PSG_215039 - Draft Guidance on Alpelisib", "Other", "Guidance", "2026-02-27", 2026, 2, "2026-02-27", "2026-04-29", "2026-02-27 19:44:36", null, 1, 0, "09000064b91e0196"], ["FDA-2007-D-0369-2493", "FDA", "FDA-2007-D-0369", "PSG_212306 - Draft Guidance on Selinexor", "Other", "Guidance", "2026-02-27", 2026, 2, "2026-02-27", "2026-04-29", "2026-02-27 19:40:55", null, 1, 0, "09000064b91e0182"], ["FDA-2007-D-0369-2498", "FDA", "FDA-2007-D-0369", "PSG_213953 - Draft Guidance on Testosterone Undecanoate", "Other", "Guidance", "2026-02-27", 2026, 2, "2026-02-27", "2026-04-29", "2026-02-27 19:42:31", null, 1, 0, "09000064b91e018c"], ["FDA-2007-D-0369-2472", "FDA", "FDA-2007-D-0369", "PSG_050440 - Draft Guidance on Cephalexin", "Other", "Guidance", "2026-02-27", 2026, 2, "2026-02-27", "2026-04-29", "2026-02-27 19:34:04", null, 1, 0, "09000064b91e013a"], ["FDA-2007-D-0369-2485", "FDA", "FDA-2007-D-0369", "PSG_208171 - Draft Guidance on Ferric Derisomaltose", "Other", "Guidance", "2026-02-27", 2026, 2, "2026-02-27", "2026-04-29", "2026-02-27 19:38:28", null, 1, 0, "09000064b91e015e"], ["FDA-2007-D-0369-2501", "FDA", "FDA-2007-D-0369", "PSG_214522 - Draft Guidance on Tadalafil", "Other", "Guidance", "2026-02-27", 2026, 2, "2026-02-27", "2026-04-29", "2026-02-27 19:44:01", null, 1, 0, "09000064b91e0192"], ["FDA-2007-D-0369-2491", "FDA", "FDA-2007-D-0369", "PSG_212268 - Draft Guidance on Asenapine", "Other", "Guidance", "2026-02-27", 2026, 2, "2026-02-27", "2026-04-29", "2026-02-27 19:40:16", null, 1, 0, "09000064b91e017e"], ["FDA-2007-D-0369-2477", "FDA", "FDA-2007-D-0369", "PSG_204017 - Draft Guidance on Ethinyl Estradiol; Levonorgestrel", "Other", "Guidance", "2026-02-27", 2026, 2, "2026-02-27", "2026-04-29", "2026-02-27 19:35:51", null, 1, 0, "09000064b91e014e"], ["FDA-2007-D-0369-2496", "FDA", "FDA-2007-D-0369", "PSG_213004 - Draft Guidance on Amoxicillin; Omeprazole Magnesium; Rifabutin", "Other", "Guidance", "2026-02-27", 2026, 2, "2026-02-27", "2026-04-29", "2026-02-27 19:41:55", null, 1, 0, "09000064b91e0188"], ["FDA-2007-D-0369-2434", "FDA", "FDA-2007-D-0369", "PSG_018859 - Draft Guidance on Ribavirin", "Other", "Guidance", "2026-02-27", 2026, 2, "2026-02-27", "2026-04-29", "2026-02-27 19:19:33", null, 1, 0, "09000064b91df4c8"], ["FDA-2007-D-0369-2431", "FDA", "FDA-2007-D-0369", "PSG_017874 - Draft Guidance on Scopolamine", "Other", "Guidance", "2026-02-27", 2026, 2, "2026-02-27", "2026-04-29", "2026-02-27 19:18:30", null, 1, 0, "09000064b91df463"], ["FDA-2007-D-0369-2449", "FDA", "FDA-2007-D-0369", "PSG_020538 - Draft Guidance on Estradiol", "Other", "Guidance", "2026-02-27", 2026, 2, "2026-02-27", "2026-04-29", "2026-02-27 19:24:10", null, 1, 0, "09000064b91df4f6"], ["FDA-2007-D-0369-2462", "FDA", "FDA-2007-D-0369", "PSG_021588 - Draft Guidance on Imatinib Mesylate", "Other", "Guidance", "2026-02-27", 2026, 2, "2026-02-27", "2026-04-29", "2026-02-27 19:29:47", null, 1, 0, "09000064b91e0125"], ["FDA-2007-D-0369-2513", "FDA", "FDA-2007-D-0369", "PSG_216675 - Draft Guidance on Perfluorohexyloctane", "Other", "Guidance", "2026-02-27", 2026, 2, "2026-02-27", "2026-04-29", "2026-02-27 19:47:39", null, 1, 0, "09000064b91e01b8"], ["FDA-2007-D-0369-2510", "FDA", "FDA-2007-D-0369", "PSG_216318 - Draft Guidance on Testosterone Cypionate", "Other", "Guidance", "2026-02-27", 2026, 2, "2026-02-27", "2026-04-29", "2026-02-27 19:46:43", null, 1, 0, "09000064b91e01b1"], ["FDA-2007-D-0369-2458", "FDA", "FDA-2007-D-0369", "PSG_021351 - Draft Guidance on Oxybutynin", "Other", "Guidance", "2026-02-27", 2026, 2, "2026-02-27", "2026-04-29", "2026-02-27 19:27:00", null, 1, 0, "09000064b91e011d"], ["FDA-2007-D-0369-2456", "FDA", "FDA-2007-D-0369", "PSG_021306 - Draft Guidance on Buprenorphine", "Other", "Guidance", "2026-02-27", 2026, 2, "2026-02-27", "2026-04-29", "2026-02-27 19:26:18", null, 1, 0, "09000064b91e0119"], ["FDA-2007-D-0369-2505", "FDA", "FDA-2007-D-0369", "PSG_215352 - Draft Guidance on Phenylephrine Hydrochloride; Tropicamide", "Other", "Guidance", "2026-02-27", 2026, 2, "2026-02-27", "2026-04-29", "2026-03-27 09:00:14", null, 1, 0, "09000064b91e019a"], ["FDA-2007-D-0369-2436", "FDA", "FDA-2007-D-0369", "PSG_019081 - Draft Guidance on Estradiol", "Other", "Guidance", "2026-02-27", 2026, 2, "2026-02-27", "2026-04-29", "2026-02-27 19:20:10", null, 1, 0, "09000064b91df4cc"], ["FDA-2007-D-0369-2455", "FDA", "FDA-2007-D-0369", "PSG_021258 - Draft Guidance on Estradiol; Levonorgestrel", "Other", "Guidance", "2026-02-27", 2026, 2, "2026-02-27", "2026-04-29", "2026-02-27 19:25:50", null, 1, 0, "09000064b91e010c"], ["FDA-2007-D-0369-2451", "FDA", "FDA-2007-D-0369", "PSG_020831 - Draft Guidance on Formoterol Fumarate", "Other", "Guidance", "2026-02-27", 2026, 2, "2026-02-27", "2026-04-29", "2026-02-27 19:24:44", null, 1, 0, "09000064b91e0104"], ["FDA-2007-D-0369-2450", "FDA", "FDA-2007-D-0369", "PSG_020612 - Draft Guidance on Lidocaine", "Other", "Guidance", "2026-02-27", 2026, 2, "2026-02-27", "2026-04-29", "2026-02-27 19:24:27", null, 1, 0, "09000064b91df4f8"], ["FDA-2007-D-0369-2430", "FDA", "FDA-2007-D-0369", "PSG_017628 - Draft Guidance on Tolmetin Sodium", "Other", "Guidance", "2026-02-27", 2026, 2, "2026-02-27", "2026-04-29", "2026-02-27 19:18:11", null, 1, 0, "09000064b91df461"], ["FDA-2007-D-0369-2465", "FDA", "FDA-2007-D-0369", "PSG_021986 - Draft Guidance on Dasatinib", "Other", "Guidance", "2026-02-27", 2026, 2, "2026-02-27", "2026-04-29", "2026-02-27 19:31:13", null, 1, 0, "09000064b91e012b"], ["FDA-2007-D-0369-2483", "FDA", "FDA-2007-D-0369", "PSG_208036 - Draft Guidance on Barium Sulfate", "Other", "Guidance", "2026-02-27", 2026, 2, "2026-02-27", "2026-04-29", "2026-02-27 19:37:51", null, 1, 0, "09000064b91e015a"], ["FDA-2007-D-0369-2468", "FDA", "FDA-2007-D-0369", "PSG_022198 - Draft Guidance on Granisetron", "Other", "Guidance", "2026-02-27", 2026, 2, "2026-02-27", "2026-04-29", "2026-02-27 19:32:47", null, 1, 0, "09000064b91e0131"], ["FDA-2007-D-0369-2470", "FDA", "FDA-2007-D-0369", "PSG_022395 - Draft Guidance on Capsaicin", "Other", "Guidance", "2026-02-27", 2026, 2, "2026-02-27", "2026-04-29", "2026-02-27 19:33:25", null, 1, 0, "09000064b91e0135"], ["FDA-2007-D-0369-2518", "FDA", "FDA-2007-D-0369", "PSG_217514 - Draft Guidance on Dabrafenib Mesylate", "Other", "Guidance", "2026-02-27", 2026, 2, "2026-02-27", "2026-04-29", "2026-02-27 19:49:32", null, 1, 0, "09000064b91e01cf"], ["FDA-2007-D-0369-2478", "FDA", "FDA-2007-D-0369", "PSG_205395 - Draft Guidance on Cobicistat; Darunavir Ethanolate", "Other", "Guidance", "2026-02-27", 2026, 2, "2026-02-27", "2026-04-29", "2026-02-27 19:36:14", null, 1, 0, "09000064b91e0150"], ["FDA-2007-D-0369-2487", "FDA", "FDA-2007-D-0369", "PSG_210136 - Draft Guidance on Buprenorphine", "Other", "Guidance", "2026-02-27", 2026, 2, "2026-02-27", "2026-04-29", "2026-02-27 19:39:03", null, 1, 0, "09000064b91e016c"], ["FDA-2007-D-0369-2502", "FDA", "FDA-2007-D-0369", "PSG_214826 - Draft Guidance on Lorazepam", "Other", "Guidance", "2026-02-27", 2026, 2, "2026-02-27", "2026-04-29", "2026-02-27 19:44:20", null, 1, 0, "09000064b91e0194"], ["FDA-2007-D-0369-2504", "FDA", "FDA-2007-D-0369", "PSG_215110 - Draft Guidance on Glecaprevir; Pibrentasvir", "Other", "Guidance", "2026-02-27", 2026, 2, "2026-02-27", "2026-04-29", "2026-02-27 19:44:51", null, 1, 0, "09000064b91e0198"], ["FDA-2007-D-0369-2474", "FDA", "FDA-2007-D-0369", "PSG_202155 - Draft Guidance on Apixaban", "Other", "Guidance", "2026-02-27", 2026, 2, "2026-02-27", "2026-04-29", "2026-02-27 19:34:51", null, 1, 0, "09000064b91e013e"], ["FDA-2007-D-0369-2499", "FDA", "FDA-2007-D-0369", "PSG_214187 - Draft Guidance on Sofosbuvir; Velpatasvir", "Other", "Guidance", "2026-02-27", 2026, 2, "2026-02-27", "2026-04-29", "2026-02-27 19:43:04", null, 1, 0, "09000064b91e018e"], ["FDA-2007-D-0369-2471", "FDA", "FDA-2007-D-0369", "PSG_022549 - Draft Guidance on Loxapine", "Other", "Guidance", "2026-02-27", 2026, 2, "2026-02-27", "2026-04-29", "2026-02-27 19:33:45", null, 1, 0, "09000064b91e0138"], ["FDA-2007-D-0369-2463", "FDA", "FDA-2007-D-0369", "PSG_021590 - Draft Guidance on Clozapine", "Other", "Guidance", "2026-02-27", 2026, 2, "2026-02-27", "2026-04-29", "2026-02-27 19:30:34", null, 1, 0, "09000064b91e0127"], ["FDA-2007-D-0369-2452", "FDA", "FDA-2007-D-0369", "PSG_020870 - Draft Guidance on Estradiol; Norethindrone Acetate", "Other", "Guidance", "2026-02-27", 2026, 2, "2026-02-27", "2026-04-29", "2026-02-27 19:25:03", null, 1, 0, "09000064b91e0106"], ["FDA-2007-D-0369-2445", "FDA", "FDA-2007-D-0369", "PSG_020310 - Draft Guidance on Ketoconazole", "Other", "Guidance", "2026-02-27", 2026, 2, "2026-02-27", "2026-04-29", "2026-02-27 19:22:59", null, 1, 0, "09000064b91df4ee"]], "truncated": false, "filtered_table_rows_count": 110, "expanded_columns": [], "expandable_columns": [], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "units": {}, "query": {"sql": "select id, agency_id, docket_id, title, document_type, subtype, posted_date, posted_year, posted_month, comment_start_date, comment_end_date, last_modified, fr_doc_num, open_for_comment, withdrawn, object_id from documents where \"agency_id\" = :p0 and \"document_type\" = :p1 order by comment_end_date desc limit 101", "params": {"p0": "FDA", "p1": "Other"}}, "facet_results": {"agency_id": {"name": "agency_id", "type": "column", "hideable": false, "toggle_url": "/open_comments/documents.json?agency_id=FDA&document_type=Other", "results": [{"value": "FDA", "label": "FDA", "count": 110, "toggle_url": "https://regs.datadawn.org/open_comments/documents.json?document_type=Other", "selected": true}], "truncated": false}, "document_type": {"name": "document_type", "type": "column", "hideable": false, "toggle_url": "/open_comments/documents.json?agency_id=FDA&document_type=Other", "results": [{"value": "Other", "label": "Other", "count": 110, "toggle_url": "https://regs.datadawn.org/open_comments/documents.json?agency_id=FDA", "selected": true}], "truncated": false}}, "suggested_facets": [{"name": "docket_id", "toggle_url": "https://regs.datadawn.org/open_comments/documents.json?agency_id=FDA&document_type=Other&_facet=docket_id"}, {"name": "subtype", "toggle_url": "https://regs.datadawn.org/open_comments/documents.json?agency_id=FDA&document_type=Other&_facet=subtype"}, {"name": "posted_date", "toggle_url": "https://regs.datadawn.org/open_comments/documents.json?agency_id=FDA&document_type=Other&_facet=posted_date"}, {"name": "posted_month", "toggle_url": "https://regs.datadawn.org/open_comments/documents.json?agency_id=FDA&document_type=Other&_facet=posted_month"}, {"name": "comment_start_date", "toggle_url": "https://regs.datadawn.org/open_comments/documents.json?agency_id=FDA&document_type=Other&_facet=comment_start_date"}, {"name": "comment_end_date", "toggle_url": "https://regs.datadawn.org/open_comments/documents.json?agency_id=FDA&document_type=Other&_facet=comment_end_date"}, {"name": "posted_date", "type": "date", "toggle_url": "https://regs.datadawn.org/open_comments/documents.json?agency_id=FDA&document_type=Other&_facet_date=posted_date"}, {"name": "comment_start_date", "type": "date", "toggle_url": "https://regs.datadawn.org/open_comments/documents.json?agency_id=FDA&document_type=Other&_facet_date=comment_start_date"}, {"name": "comment_end_date", "type": "date", "toggle_url": "https://regs.datadawn.org/open_comments/documents.json?agency_id=FDA&document_type=Other&_facet_date=comment_end_date"}, {"name": "last_modified", "type": "date", "toggle_url": "https://regs.datadawn.org/open_comments/documents.json?agency_id=FDA&document_type=Other&_facet_date=last_modified"}], "next": "2026-04-29,FDA-2007-D-0369-2445", "next_url": "https://regs.datadawn.org/open_comments/documents.json?agency_id=FDA&document_type=Other&_next=2026-04-29%2CFDA-2007-D-0369-2445&_sort_desc=comment_end_date", "private": false, "allow_execute_sql": true, "query_ms": 8.578142849728465, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}